<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recash test site | Lynn Jordan | Activity</title>
	<link>https://recash.wpsoul.net/members/parrotcomic48/activity/</link>
	<atom:link href="https://recash.wpsoul.net/members/parrotcomic48/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Lynn Jordan.</description>
	<lastBuildDate>Mon, 18 May 2026 15:41:24 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">a0969f7756ee1ac24ccd9d5d7127025c</guid>
				<title>Lynn Jordan posted an update: Among brain tumors, Medulloblastoma (MB) is one of the most [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/47690/</link>
				<pubDate>Wed, 11 Dec 2024 08:29:35 +0000</pubDate>

									<content:encoded><![CDATA[<p>Among brain tumors, Medulloblastoma (MB) is one of the most common, malignant, pediatric tumors of the cerebellum. It accounts for ~20% of all childhood central nervous system (CNS) tumors. Despite, tremendous advances in drug development processes, as well as novel drugs for MB the morbidity and mortality rates, remain high. Craniospinal&hellip;<span class="activity-read-more" id="activity-read-more-47690"><a href="https://recash.wpsoul.net/activity/p/47690/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">57e9872761ebb0e9b05cc0dd709efe87</guid>
				<title>Lynn Jordan became a registered member</title>
				<link>https://recash.wpsoul.net/activity/p/47582/</link>
				<pubDate>Wed, 11 Dec 2024 08:15:45 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>